Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Operating Expenses: 2009-2024

Historic Operating Expenses for Sunshine Biopharma (SBFM) over the last 14 years, with Dec 2024 value amounting to $20.7 million.

  • Sunshine Biopharma's Operating Expenses rose 6.31% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.9 million, marking a year-over-year increase of 16.52%. This contributed to the annual value of $20.7 million for FY2024, which is 19.96% up from last year.
  • Sunshine Biopharma's Operating Expenses amounted to $20.7 million in FY2024, which was up 19.96% from $17.2 million recorded in FY2023.
  • In the past 5 years, Sunshine Biopharma's Operating Expenses registered a high of $29.5 million during FY2022, and its lowest value of $638,231 during FY2020.
  • In the last 3 years, Sunshine Biopharma's Operating Expenses had a median value of $20.7 million in 2024 and averaged $22.5 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 812.63% in 2022, then slumped by 41.64% in 2023.
  • Over the past 5 years, Sunshine Biopharma's Operating Expenses (Yearly) stood at $638,231 in 2020, then skyrocketed by 406.98% to $3.2 million in 2021, then spiked by 812.63% to $29.5 million in 2022, then slumped by 41.64% to $17.2 million in 2023, then increased by 19.96% to $20.7 million in 2024.